Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation.

Gündüz D, Troidl C, Tanislav C, Rohrbach S, Hamm C, Aslam M.

Front Physiol. 2019 Nov 7;10:1387. doi: 10.3389/fphys.2019.01387. eCollection 2019.

2.

Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.

Krieg VJ, Hobohm L, Liebetrau C, Guth S, Kölmel S, Troidl C, Mayer E, Konstantinides SV, Wiedenroth CB, Lankeit M.

Thromb Res. 2019 Oct 31;185:20-26. doi: 10.1016/j.thromres.2019.10.025. [Epub ahead of print]

3.

Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA.

Lipps C, Northe P, Figueiredo R, Rohde M, Brahmer A, Krämer-Albers EM, Liebetrau C, Wiedenroth CB, Mayer E, Kriechbaum SD, Dörr O, Nef H, Hamm CW, Keller T, Troidl C.

Biomolecules. 2019 Oct 29;9(11). pii: E666. doi: 10.3390/biom9110666.

4.

Prognostic performance of the ESC SCORE and its German recalibrated versions in primary and secondary prevention.

Elsner LK, Jeinsen BV, Grün D, Wolter JS, Weferling M, Diouf K, Kriechbaum S, Troidl C, Dörr O, Nef H, Hamm CW, Liebetrau C, Keller T.

Eur J Prev Cardiol. 2019 Aug 18:2047487319868034. doi: 10.1177/2047487319868034. [Epub ahead of print] No abstract available.

PMID:
31423815
5.

Impact of Vascular Function on Maximum Power Output in Elite Handball Athletes.

Bauer P, Kraushaar L, Most A, Hölscher S, Tajmiri-Gondai S, Dörr O, Troidl C, Bauer T, Nef H, Hamm CW, Keller T.

Res Q Exerc Sport. 2019 Dec;90(4):600-608. doi: 10.1080/02701367.2019.1639602. Epub 2019 Aug 9.

PMID:
31397640
6.

Effects on the Profile of Circulating miRNAs after Single Bouts of Resistance Training with and without Blood Flow Restriction-A Three-Arm, Randomized Crossover Trial.

Vogel J, Niederer D, Engeroff T, Vogt L, Troidl C, Schmitz-Rixen T, Banzer W, Troidl K.

Int J Mol Sci. 2019 Jul 2;20(13). pii: E3249. doi: 10.3390/ijms20133249.

7.

No evidence for humoral autoimmunity against cardiomyocytes, adrenergic or muscarinic receptors in patients with Tako-Tsubo cardiomyopathy.

Juenemann M, Nef H, Möllmann H, Singh P, Troidl C, Schramm P, Kaps M, Gerriets T, Blaes F, Tschernatsch M.

Immunobiology. 2019 Mar;224(2):220-222. doi: 10.1016/j.imbio.2018.11.005. Epub 2018 Nov 15.

PMID:
30554740
8.

Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Ortlieb RM, Boeder N, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Nov;41(11):1474-1479. doi: 10.1002/clc.23089. Epub 2018 Nov 16.

9.

Protective role of soluble adenylyl cyclase against reperfusion-induced injury of cardiac cells.

Rinaldi L, Pozdniakova S, Jayarajan V, Troidl C, Abdallah Y, Aslam M, Ladilov Y.

Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):252-260. doi: 10.1016/j.bbadis.2018.07.021. Epub 2018 Jul 22.

PMID:
30044950
10.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Sep;41(9):1164-1169. doi: 10.1002/clc.22996. Epub 2018 Aug 20.

11.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

12.

Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Liebetrau C, Kim WK, Meyer A, Arsalan M, Gaede L, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Dörr O, Schillinger S, Troidl C, Nef HM, Hamm CW, Walther T, Möllmann H.

Am J Cardiol. 2017 Oct 1;120(7):1180-1186. doi: 10.1016/j.amjcard.2017.06.069. Epub 2017 Jul 14.

PMID:
28826900
13.

Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome.

Lynch TL 4th, Kuster DWD, Gonzalez B, Balasubramanian N, Nair N, Day S, Calvino JE, Tan Y, Liebetrau C, Troidl C, Hamm CW, Güçlü A, McDonough B, Marian AJ, van der Velden J, Seidman CE, Huggins GS, Sadayappan S.

JACC Basic Transl Sci. 2017 Apr;2(2):122-131. doi: 10.1016/j.jacbts.2016.12.001. Epub 2016 Dec 19.

14.

Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y12 Receptor and Aggregation.

Gündüz D, Tanislav C, Sedding D, Parahuleva M, Santoso S, Troidl C, Hamm CW, Aslam M.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E269. doi: 10.3390/ijms18020269.

15.

Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.

Lynch TL 4th, Ismahil MA, Jegga AG, Zilliox MJ, Troidl C, Prabhu SD, Sadayappan S.

J Mol Cell Cardiol. 2017 Jan;102:83-93. doi: 10.1016/j.yjmcc.2016.12.002. Epub 2016 Dec 10.

16.

Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction.

Liebetrau C, Gaede L, Wolter JS, Homann J, Meyer A, Dörr O, Nef HM, Troidl C, Hamm CW, Möllmann H, Richards AM, Pemberton CJ.

Biomarkers. 2017 May - Jun;22(3-4):304-310. doi: 10.1080/1354750X.2016.1252965. Epub 2016 Nov 22.

PMID:
27775442
17.

N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro.

Lipps C, Nguyen JH, Pyttel L, Lynch TL 4th, Liebetrau C, Aleshcheva G, Voss S, Dörr O, Nef HM, Möllmann H, Hamm CW, Sadayappan S, Troidl C.

J Mol Cell Cardiol. 2016 Oct;99:47-56. doi: 10.1016/j.yjmcc.2016.09.003. Epub 2016 Sep 8.

18.

Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice.

Kaur H, Takefuji M, Ngai CY, Carvalho J, Bayer J, Wietelmann A, Poetsch A, Hoelper S, Conway SJ, Möllmann H, Looso M, Troidl C, Offermanns S, Wettschureck N.

Circ Res. 2016 Jun 10;118(12):1906-17. doi: 10.1161/CIRCRESAHA.116.308643. Epub 2016 May 2. Erratum in: Circ Res. 2016 Sep 16;119(7):e109.

PMID:
27140435
19.

Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery.

Gaede L, Liebetrau C, Blumenstein J, Troidl C, Dörr O, Kim WK, Gottfried K, Voss S, Berkowitsch A, Walther T, Nef H, Hamm CW, Möllmann H.

Nephrol Dial Transplant. 2016 May;31(5):760-6. doi: 10.1093/ndt/gfw007. Epub 2016 Mar 2.

PMID:
26940124
20.

Effect of Renal Sympathetic Denervation on Specific MicroRNAs as an Indicator of Reverse Remodeling Processes in Hypertensive Heart Disease.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Lankes S, Guckel D, Boeder N, Voss S, Bauer T, Hamm C, Nef H.

J Clin Hypertens (Greenwich). 2016 Jun;18(6):497-502. doi: 10.1111/jch.12797. Epub 2016 Feb 24.

Supplemental Content

Loading ...
Support Center